发明名称 Vasodilator Formulation and Method of Use
摘要 A topically admimstrable vasodilator formulation comprises arginine and/or one or more derivatives thereof, black pepper extract and/or one or more components or derivatives thereof; and peppermint extract and/or one or more components or derivatives thereof. The formulation may further comprise rosemary oil, a penetration enhancers, an ecdysteroid and/or one or more other agents that enhance the vasodilator activity of the formulation. The valodilator formulation may be suitable for treating or preventing a disease, disorder or condition associated with a decrease and/or impairment of blood flow in a subject by topically administration to the subject.
申请公布号 US2016256509(A1) 申请公布日期 2016.09.08
申请号 US201415032370 申请日期 2014.11.04
申请人 ATP INSTITUTE PTY LTD 发明人 Legge Matthew
分类号 A61K36/67;A61K36/534;A61K36/53;A61K8/06;A61K9/00;A61K47/46;A61K47/12;A61K8/97;A61K8/67;A61K9/107;A61K36/185;A61K31/355;A61K31/198;A61K45/06;A61Q7/00;A61Q19/08;A61K8/44 主分类号 A61K36/67
代理机构 代理人
主权项 1. A topically administrable vasodilator formulation comprising: (i) arginine and/or one or more derivatives thereof; (ii) black pepper extract and/or one or more components or derivatives thereof; and (iii) peppermint extract and/or one or more components or derivatives thereof.
地址 Loganholme, Queensland AU